Home » Newsletters » BioWorld Science

BioWorld Science

April 21, 2016

View Archived Issues

Johnson & Johnson profiles activities of first quarter 2016

First phase I clinical results for IRX-4204 as potential treatment for PD

Roche reviews pipeline progress of first quarter 2016

Novel ERK1/2 inhibitor ASN-007 shows strong antitumor activity in multiple RAS mutant models

Spectrum's Evomela receives 7 years of orphan drug exclusivity

New model of PMM2-CDG recapitulates human disease in mice

Bristol-Myers Squibb patents NS5B inhibitors

FDA removes clinical hold on Cara Therapeutics' CR-845

N & N Pharmaceuticals begins phase I trial of N-MCT

AbbVie enters 5-year collaboration agreement with University of Chicago

Venclexta available in U.S. through Biologics

AbbVie and Argenx collaborate on anti-GARP antibody candidate ARGX-115

BioMarin reports phase I/II data on BMN-270

Eiger licenses PEGylated interferon lambda-1a rights from Bristol-Myers Squibb

Phase IIb/III study of bimagrumab in sporadic inclusion body myositis misses primary endpoint

Phase I/II trial explores use of SHR-3680 for metastatic castration-resistant prostate cancer

Pluristem enters licensing agreement for placental cell therapy patent

BioMarin updates findings from phase II study of vosoritide in achondroplasia

Boehringer Ingelheim initiates phase I study of anti-CX3CR1 Nanobody from Ablynx alliance

Genticel reports additional 12-month data from phase II trial of GTL-001

Durvalumab plus gefitinib active in NSCLC patients with EGFR mutations

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Anticancer drug exerts potent HIV antiviral effects
BioWorld Science
A new isoform of proliferating cell nuclear antigen (PCNA) – cancer-associated PCNA (caPCNA) – that is specifically expressed in cancer tissues has been reported....